These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21906355)

  • 1. The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?
    Duffy MJ; Mullooly M; O'Donovan N; Sukor S; Crown J; Pierce A; McGowan PM
    Clin Proteomics; 2011 Jun; 8(1):9. PubMed ID: 21906355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ADAMs family of proteases as targets for the treatment of cancer.
    Mullooly M; McGowan PM; Crown J; Duffy MJ
    Cancer Biol Ther; 2016 Aug; 17(8):870-80. PubMed ID: 27115328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functions of 'A disintegrin and metalloproteases (ADAMs)' in the mammalian nervous system.
    Hsia HE; Tüshaus J; Brummer T; Zheng Y; Scilabra SD; Lichtenthaler SF
    Cell Mol Life Sci; 2019 Aug; 76(16):3055-3081. PubMed ID: 31236626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMs in cancer cell proliferation and progression.
    Mochizuki S; Okada Y
    Cancer Sci; 2007 May; 98(5):621-8. PubMed ID: 17355265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ADAMs in cancer formation and progression.
    Duffy MJ; McKiernan E; O'Donovan N; McGowan PM
    Clin Cancer Res; 2009 Feb; 15(4):1140-4. PubMed ID: 19228719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets.
    Dreymueller D; Uhlig S; Ludwig A
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L325-43. PubMed ID: 25480335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
    Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
    J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells.
    Ebsen H; Schröder A; Kabelitz D; Janssen O
    PLoS One; 2013; 8(10):e76853. PubMed ID: 24130797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.
    Matthews AL; Noy PJ; Reyat JS; Tomlinson MG
    Platelets; 2017 Jun; 28(4):333-341. PubMed ID: 27256961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM Proteases and Gastrointestinal Function.
    Jones JC; Rustagi S; Dempsey PJ
    Annu Rev Physiol; 2016; 78():243-76. PubMed ID: 26667078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and cellular localization of metalloproteases ADAMs in high graded carotid artery lesions.
    Pelisek J; Pongratz J; Deutsch L; Reeps C; Stadlbauer T; Eckstein HH
    Scand J Clin Lab Invest; 2012 Dec; 72(8):648-56. PubMed ID: 23101757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ADAMs in disease pathophysiology.
    Duffy MJ; McKiernan E; O'Donovan N; McGowan PM
    Clin Chim Acta; 2009 May; 403(1-2):31-6. PubMed ID: 19408347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes.
    Ebsen H; Lettau M; Kabelitz D; Janssen O
    Mol Immunol; 2015 Jun; 65(2):416-28. PubMed ID: 25745808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ADAM metalloproteinases.
    Edwards DR; Handsley MM; Pennington CJ
    Mol Aspects Med; 2008 Oct; 29(5):258-89. PubMed ID: 18762209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic processing of delta-like 1 by ADAM proteases.
    Dyczynska E; Sun D; Yi H; Sehara-Fujisawa A; Blobel CP; Zolkiewska A
    J Biol Chem; 2007 Jan; 282(1):436-44. PubMed ID: 17107962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.
    Carl-McGrath S; Lendeckel U; Ebert M; Roessner A; Röcken C
    Int J Oncol; 2005 Jan; 26(1):17-24. PubMed ID: 15586220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (Make) stick and cut loose--disintegrin metalloproteases in development and disease.
    Tousseyn T; Jorissen E; Reiss K; Hartmann D
    Birth Defects Res C Embryo Today; 2006 Mar; 78(1):24-46. PubMed ID: 16622847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells.
    Micocci KC; Moritz MN; Lino RL; Fernandes LR; Lima AG; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
    Biochimie; 2016; 128-129():174-82. PubMed ID: 27554339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal ADAM10 and 17: Their Physiological and Medical Meanings.
    Kato T; Hagiyama M; Ito A
    Front Cell Dev Biol; 2018; 6():153. PubMed ID: 30460232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes.
    Camodeca C; Nuti E; Tosetti F; Poggi A; D'Arrigo C; Zocchi MR; Rossello A
    ChemMedChem; 2018 Oct; 13(19):2119-2131. PubMed ID: 30102846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.